Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer

類似資料

• Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer
  著者:: Varga, Zsuzsanna, 等
  出版事項: (2013)
• Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
  著者:: Buus, Richard, 等
  出版事項: (2021)
• Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
  著者:: Buus, Richard, 等
  出版事項: (2016)
• Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study
  著者:: Buus, Richard, 等
  出版事項: (2021)
• Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay
  著者:: Denkert, Carsten, 等
  出版事項: (2012)